MANILA, Philippines — The country’s Food and Drug Administration granted two more hospitals compassionate special permits to use the anti-parasitic drug ivermectin as a treatment for COVID-19, its chief said Tuesday. The FDA chief also said the hospitals that requested CSPs for ivermectin use gave the drug to mild and moderate COVID-19 cases. The cheap anti-parasitic drug is being touted as a possible treatment for or prophylactic against COVID-19 despite thin scientific evidence on its efficacy to treat or prevent COVID-19. The World Health Organization does not recommend ivermectin on COVID-19 patients except in the context of clinical trial. Outside the country, dozens of clinical trials on its use for the treatment of COVID-19 are still ongoing.

Source: Philippine Star April 27, 2021 03:00 UTC